• Home
  • Agenda
  • Speakers
  • Partners
    • Commercial Partners
    • Media Partners
    • Become a Commercial Partner
    • Host a webinar
    • Note to Partners
  • Summit Details
    • Venue & Accommodation
    • FAQS
    • Sign up for conference updates
    • Contact Us
  • Attendance
    • Why attend
    • Gallery
    • Audience Breakdown
    • Poster Competition
    • Ticket details
  • DDF Summits
    • DDF Global
    • DDF Asia
  • LOG IN
  • Book now
DelSiTech
www.delsitech.com

DelSiTech is a drug delivery and drug development company, based in Finland and is the leader in fully biodegradable, amorphous silica-based long-acting controlled release. DelSiTech's core technology, Silica Matrix, enables the delivery of virtually any API with truly controlled release over durations from a day to a year. DelSiTech Silica Matrix technology enables parenteral drug delivery through a wide variety of routes of administration, in addition to topical ocular applications of the patent protected silica composite technology. DelSiTech is currently developing controlled release products based on its Silica Matrix technology across a wide range of therapeutic areas for partners such as Bayer and the Bill & Melinda Gates Foundation

Back

Information


Mark Allen Group
St Jude’s Church
Dulwich Road
London
SE24 0PB
United Kingdom

Main reception at Publication company: +44 (0)20 7738 5454


Additional Enquiries:


Alexandra Krcho, Account Director +44 (0)20 3874 9205
Adrian Forde, Delegate Sales Director + 44 (0)20 3874 9209

[Privacy Policy] – Please read our privacy policy to understand how we process, use, and safeguard your data.

Further information


Privacy policy

Cookie policy

Terms and conditions

Booking terms and conditions